Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response

NCT03153488 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03153488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2018
Completion date
December 1, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder